Inoviem raises €500k in seed funding
CRO Inoviem Scientific has raised €500,000 ($566,000) in seed funding with Cap Innov’Est.
Archives for February 12, 2015
AstraZeneca selects Clinigen for antibiotic access program
Clinigen has initiated an international global access program for AstraZeneca’s investigational antibiotic, CAZ-AVI (ceftazidame-avibactam).
Suboxone sales down as opioid addiction drug market intensifies
Opioid addiction drug Suboxone lost market share in 2014 according to newly independent Indivior, whose management says it is not intimidated by increased competition.
update
Switzerland rejects allegations it offers drug fakers easy route to the EU
The increase in dodgy erectile dysfunction drugs seized in Switzerland does not mean the country is a weak point for counterfeiters shipping to Europe according to Swissmedic.
No GVK Bioscience trialled drugs under EMA spotlight are sold in Switzerland says Swissmedic
None of the drugs the EMA wants suspended over concerns about data manipulation at GVK Biosciences are sold in Switzerland says Swissmedic.
AMRI looks to close API facility in Wales as part of network realignment
AMRI has announced plans to close an API development and manufacturing plant in Wales, UK, after efforts to establish it as a conduit between the US and Europe were deemed unsuccessful.
Ex-Unigene execs who run Enteris add API contracting service to delivery tech licensing business
Enteris BioPharma has broadened its business beyond drug delivery tech licensing and launched a contract API manufacturing service.